SUMMARY We previously published results of investigations which indicated that the combination of mannitol, which acts as a free radical scavenger, and perfluorochemicals (PFC), which have a strong oxygen-carrying capacity, can be therapeutic in cases of brain infarction. The present experiment tested the hypothesis that the effectiveness of such treatment could be increased by an optimal combination of such scavengers and other chemicals.
HAVING BECOME AWARE of the possible protective effects of 20% mannitol on the ischemic brain, we have reported clinical studies relating to this 1 
"
3 and have investigated the effects of mannitol on ischemia over the past decade, using various canine models. 4 " 6 We have also demonstrated that the administration of perfluorochemicals (PFC), originally developed as an artificial blood substitute, and of mannitol, further increases the anti-ischemic capabilities. 7 " 9 These effects have also been demonstrated by us in clinical cases when these drugs are administered in the acute phase of cerebral infarction. 10 In recent years, a new hypothesis concerning the involvement of the lipid peroxidation caused by active oxygens which occurs at CNS cytomembranes in the process of cerebral damage, has attracted considerable attention."' 12 We surmised that the protective effects of mannitol on the ischemic brain may in part be due to the capacity of mannitol to act as a scavenger of active oxygens.
In the present study, we have made a comparative investigation of the protective effects of six agents,
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FIGURE 1. Occluded points of the main arteries of the canine brain and blood supply of the cerebral cortex (-*).
arteries, bilateral ophthalmic arteries, right posterior cerebral artery, right superior cerebellar artery and basilar artery were occluded by cauterization, and the right middle cerebral artery (MCA) was cannulated. Finally, the bilateral internal carotid arteries were occluded using aneurysm clips, and autologous blood was infused to the MCA from the femoral artery using a Harvard peristaltic infusion pump (Model 1310). In this manner, the blood volume flowing to the left cerebral hemisphere could be regulated at will ( fig. 2) .
B. The Experimental Procedures
Immediately following production of the model, arterial blood was infused at a speed of 20 ml/min and the normal electrical activity was maintained for one hour. In the middle of this period, the infusion pump was temporarily stopped for 30 seconds in order to confirm that normal cerebral circulation could be achieved using only the pump. Electrical activity became completely flattened within 30 seconds after interruption of perfusion. Subsequent resumption of perfusion immediately produced complete recovery of electrical activity ( fig. 3 ). Following this procedure, the drugs were administered intravenously about 15 minutes prior to the onset of ischemia. Next, blood flow was reduced to 2 ml/min for one hour. Blood flow was then made to return to 20 ml/min and the changes in electrical activity were observed for three hours thereafter.
C. Drugs and Doses
Eight groups of animals were treated using the following doses of each drug:
I. Mannitol was administered by intravenous drip infusion (over approximately 10 minutes). All other drugs were administered intravenously. For the vitamin E group, the emulsion of dl-alpha-tocopheryl nicotinate was used.
Tests were also done on two additional groups of dogs in which various combinations of drugs were given:
1 mg/kg DEXA, 10 mg/kg vitamin E and 2 g/kg mannitol (5 dogs) Following administration of the above 3 drugs, 20 ml/kg of PFC by intravenous drip (5 dogs) For the PFC, 20% Fluosol-DA (Green Cross Corporation, Osaka, Japan) was used. Due to the inhalation of 100% O 2 , the arterial O 2 pressure (P a O 2 ) rose to 400-500 mmHg. In all dogs of this group, a test dose of 3-5 ml of PFC was given intravenously prior to surgery.
IX.
X. The species-specific transient fall in blood pressure and the subsequent spontaneous recovery of normal pressure occurred in all the dogs. In those dogs which showed severe decreases, an adequate dose of hypertensive agent (Ethylephrine Hydrochloride, Effortil®) was given intravenously.
D. Electroencephalography (EEG) Recording
In the analysis of EEG, the following three points were studied: 1) Survival time", i.e., the time required from the start of brain ischemia until complete attenuation of electrical activity.
2) Recovery time 13 , i.e., the time required from recirculation until the reappearance of electrical activity.
3) Degree of recovery, i.e., the degree of recovery of electrical activity following three hours of recirculation, based upon a five-stage classification: Grade 0, complete attenuation; Grade 1, less than 30 /u.V; Grade 2, 30-50 /xV; Grade 3, 50-100 /AV; and Grade 4, more than 100 /W ( fig. 4) .
Statistical analyses were performed using Student's t test and chi square test.
Results
A. The Control Group
In the untreated control group (I), the EEG survival time was 7.4 ± 4.3 min. In five of the seven dogs, recovery of electrical activity was not seen subsequent to recirculation. In the two remaining dogs, electrical activity reappeared very slightly after two and 30 minutes. But three hours after the start of recirculation, six dogs were Grade 0 and one dog was Grade 1.
B. The Drug Group
In the vitamin E group given 10 mg/kg (II), the survival time in the EEG was 9.4 ± 6.1 min, which was not significantly longer than the time seen in the control group. The recovery time was 32.5 ± 17.9 minutes and, after three hours of recirculation, one dog was grade 4, one was Grade 2, two were Grade 1 and one was Grade 0.
In the vitamin E group given 30 mg/kg (III), the survival time was 12.0 ± 6.8 minutes and the recovery time was 3.6 ± 1.7 minutes, which was significantly faster than the recovery time in the vitamin E (10 mg/kg) group (p < 0.05, Student's t-test). The degree of recovery after three hours was as follows: three dogs were grade 4 and two dogs were Grade 3.
In the mannitol group (IV), the survival time was 10.0 ± 5.7 minutes, which was longer than that of the control group, but not statistically significant. Recovery time was 29.0 ± 20.1 minutes, and the Grades after three hours of recirculation were: Grade 4 in two dogs, grade 3 in one dog and Grade 2 in two dogs.
In the MY-103 group (V), survival time was 16.4 ± 11.5 minutes. This figure was not significantly different from the control group, but this survival time was the longest seen among the six different drug groups. The recovery time was 24.0 ± 22.2 minutes. After three hours of recirculation, one dog was Grade 3, two dogs were Grade 2 and one was Grade 1.
In the DEXA group (VI), the survival time was 4.8 ± 1.9 minutes, and the recovery time was 58.0 ± 34.9 minutes. After recirculation, one dog was Grade 3, two were Grade 2 and two were Grade 1.
In the Y-9179 group (VII), the survival time was 13.0 ± 8.9 minutes, the recovery time was 23.3 ± 12.5 minutes and the Grades after three hours of recirculation were: one Grade 1 animal, one Grade 2 animal, one Grade 3 animal and two Grade 0 animals.
In the vitamin C group (VIII), the survival time was 10.0 ± 5.6 minutes and the recovery time was 32.6 ± 33.8 minutes. After recirculation, one dog was Grade 1, three were Grade 1 and one was Grade 0.
In the group of dogs given mannitol, vitamin E and DEXA (IX), the survival time was 12.0 ± 9.4 minutes. Recovery time was 8.0 ± 2.8 minutes and all five dogs were judged as Grade 4 after three hours of recirculation.
In the group given mannitol, vitamin E, DEXA and PFC (X), four of the five animals showed some attenuation of voltage and slowing of frequency in the EEG, but complete attenuation was not seen during ischemia. In only one animal was there complete attenuation after 20 minutes of ischemia. After recirculation, the recovery time was rapid in all five dogs. All five were judged as Grade 4, continuously showing normal electrical activity after three hours of recirculation, throughout the recirculation period. The results in the six single-drug groups and the two groups given a combination of drugs are summarized in tables 1 and 2 and figure 6 . When compared to the untreated control, there were statistically significant beneficial effects (p < 0.05, chi square test) in the Vitamin E (30 mg/Kg) group, the mannitol group and the two combination therapy groups.
Discussion
In treatment during the acute period of brain ischemia, the improvement of brain metabolism and the suppression of brain edema have thus far been the primary concerns. For over a decade, we have undertaken experimental 16 " 18 and clinical studies 1 " 3 of the protective effects which mannitol can have on the ischemic brain. In recent years, we have investigated the effects of mannitol administered together with PFC, which are known to be extremely small particles, and to be potent oxygen carriers. 19 " 21 We have found that, in comparison with the administration of either agent alone, combined administration greatly suppresses the ischemic change, 7 -8 the development of ischemic brain edema, 9 and hemorrhagic infarction. 22 Furthermore, we have found in clinical cases that this combined treatment can indeed be effective. 10 The hypothesis has been advanced that tissue damage in cerebral ischemia occurs due to the lipid peroxidation of cell membranes caused by the release of free radicals,"-12 -n - 24 but subsequent work has demonstrated the involvement of a free radical reaction after rccirculation rather than during ischemia itself. 25 -26 Many problems remain, however, in the experimental methods for proving the presence of the free radical reaction.
The actual mechanism involved in mannitol's protective effect has remained uncertain, but it has become known that this drug has biochemical properties that allow it to act as a scavenger of hydroxyl radicals, 27 which are a form of highly reactive oxygen. We have consequently studied the mechanism of mannitol in brain ischemia from this perspective.
Physiological effects of vitamin E are known from Tappel et al. 28 w to include an anti-oxidant action, and from the work of Lucy 30 to include a stabilizing effect on cytomembranes. As far as this anti-oxidant action is concerned, in addition to the scavenging effects of the alkyl radicals produced during the autoxidation of lip- 2.
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V. ids, 29 it has recently been emphasized that there is a quenching effect of singlet oxygen. 31 It is thought that, due to these actions, the peroxidation reaction is suppressed. As to the stabilizing effect on cytomembranes, it is thought that, due either to the physical binding of vitamin E to membrane phospholipods, 30 or to the stabilization of nonheme proteins, 32 various abnormal reactions, such as the peroxidation reaction, are prevented.
In the present experiments, the concentration of vitamin E in the blood was about three times higher in the dogs administered 30 mg/kg than in those given 10 mg/ kg for the entire three-hour period following recirculation. 33 The recovery time was significantly shorter in the former group and the degree of recovery was also better. We consequently believe that intravenous administration of a large dose of vitamin E is effective due to its transport from the blood to its site of action, the cellular membrane. Vitamin C is known to act as a scavenger of superoxide anion (O 2~) , but in vitro experiments show its capacity to quench O 2~ is considerably weaker than that of superoxide dismutase. 34 Furthermore, although it is found that vitamin C, when present in high con- 
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centrations, can suppress free radical reaction, when present in low concentrations, it has been reported to act to the contrary, as an initiator of free radical formation. 35 At the concentration used in the present experiments, vitamin C did not have a protective effect on the ischemic brain.
Nizofenone (Y-9197) is one of the imidazole derivatives and, during ischemia, is known to suppress the consumption of energy and O 2 . It is also said to have an anti-oxidant action.
3 * In the present experiments, however, it was not so effective in protecting the ischemic brain.
Among the steroid drugs, DEXA in particular has been known to have anti-edemic properties. 37^10 It has been postulated that the actual mechanisms of DEXA action in cerebral edema may be related to its efficacy in stabilizing cytomembranes 37 and scavenging radicals. 41 The value of DEXA in ischemic brain edema has been re-examined by various researchers in both experimental and clinical studies, but conclusions as to its benefits are still controversial.
39 -42 -4 * In the present experiment, a large dose of DEXA (1 mg/kg) was administered prior to ischemia, and moderate effects were obtained, when compared with those produced by the other five drugs.
Suloctidil (MY-103) is a new drug with various known pharmacological properties. It produces improvements in the cycle of aerobic metabolism, 49 has an anti-platelet aggregative action, 49 -K and has vascular anti-spasmodic effects. 51 Recently we have found that the protective effects of MY-103 include its role as a free radical scavenger. Details of the work on the chemiluminescence of hypoxic brain will be reported elsewhere. 52 In our experiments, the effects of MY-103 varied widely, indicating that further study of this drug is required.
In the investigation of EEG survival time, no significant differences were found between the control group and each of the groups given one of the drugs. Moreover, those animals with long survival times did not consistently show favorble degrees of recovery following recirculation. In contrast, although no significant differences were found in the recover time of the various drug groups, it was seen that the shorter the recovery time (i.e., the faster the return of electrical activity following recirculation), the better was the ultimate degree of recovery of such activity. Particularly for the animals with an EEG recover}' time of less than 10 minutes, most showed recovery to Grade 3 or Grade 4. It is of interest that the degree of recovery after recirculation correlated more closely with the recovery time than with the survival time. We surmise that the favorable effects on the degree of recovery are because irreversible histological changes during ischemia are prevented by the drugs, and the metabolic structures are thereby preserved, and can effectively and rapidly utilize the oxygen and glucose supplied due to blood recirculation.
In light of the above results concerning the administration of each of these drugs alone, the following five were considered to have protective effects against brain ischemia: mannitol, vitamin E, MY-103, DEXA and Y-9197. However, the results in the MY-103, the DEXA and the Y-9197 group were not statistically significant since the number of animals was too small. The fact that the drugs which have anti-oxidant actions show protective effects on the brain suggests that free radical reaction is involved in the neuronal cell damage at the ischemic focus. Although vitamin C also has anti-oxidant property, it was not found to have therapeutic effect. It should be noted, however, that in the present study a single dose of each drug (except vitamin E) was used. Therefore, further examination of the effects of dosage using these and other drugs will be required.
Finally, examination was also made of the combined administration of three of the drugs (mannitol, vitamin E and DEXA), which were found effective when administered singly and which are known to be safe and easy to use clinically. It was found that their combined administration produced shorter recovery times and better final grades of recovery following recirculation, than the administration of one of the drugs alone. It is particularly noteworthy that addition of PFC to these three drugs prevented complete attenuation of EEG activity during one hour of brain ischemia in four of the five dogs tested, although slowing and moderate attenuation did occur. Also, immediately following recirculation, the electrical activity of the brain returned rapidly to nearly a pre-ischemic state. We believe these results clearly indicate that the combined administration of mannitol, vitamin E, DEXA and PFC produces results which are superior to the administration of only mannitol and PFC together, which we had previously advocated. 7 In the present experiments, some control studies were not performed because of the following reasons. 1) Control study for the use of oxygen inhalation. With regard to this, we had previousy investigated the effect of oxygen inhalation alone using the same experimental schedule as that of the present study, and reported that no recovery of electrical activity was seen following recirculation in all of the control group subjected to oxygen inhalation. 7 2) Control study for the hemodilution. In the animals of group X, there was about a 20% decrease in hematocrit after intravenous administration of both 20% mannitol (10 ml/kg) and PFC (20 ml/kg). In our previous study, some of the animals were given 30 ml/kg of Ringer's solution intravenously as a control for the group given mannitol and PFC. In these animals there was also a 15-20% decrease in hematacrit, but no recovery of EEG was observed following recirculation. experiments alone, but it may be that the effectiveness of this combination therapy is due to the joint effects of: 1) PFC, which has the capacity to transport 0 19.54 to the ischemic focus because of its relatively small molecular size 2) Mannitol and vitamin E, which work as antioxidants 27 ' 28 3) DEXA, which works as an anti-oxidant and stabilizer of cytomembranes 37 In future research, it would be desirable to investigate the effects of dosage and method of administration of mannitol, vitamin E, DEXA and PFC, and to apply these methods in clinical cases in the acute stage of brain ischemia.
